American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Tilray Brands, Inc.

$5.03 +1.82% NASDAQ: TLRY · 15-min delayed

NEW YORK, New York
Public · NASDAQ: TLRY
2,842 employees

Visit website Follow

$590.8MMarket cap

$821.3MRevenue · FY2025

-$2.2BNet income

2,842Employees

TLRYNASDAQ

2015IPO

About Tilray Brands, Inc.

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · NASDAQ: TLRY
Employees: 2,842
IPO date: Jan 23, 2015
Headquarters: 655 MADISON AVENUE
NEW YORK, New York 10065
Phone: 519.322.8800
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: TLRY Nasdaq
SEC CIK: 1731348
LEI: 549300I1AHR8KMMFIS52
EIN: 824310622
SIC: 2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow Tilray Brands, Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $821.3M
Net income: -$2.2B
Total assets: $2.1B
Market cap: $590.8M
Gross margin: 29.3%
Operating margin: -277.9%
Net margin: -265.6%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

FY2021

FY2022

FY2023

FY2024

FY2025

Revenue Net income

FY 2025

Financial statements

Income statement

Revenue: $821.3M
Cost of revenue: $580.7M
Gross profit: $240.6M
Operating expenses: $2.5B
Operating income: -$2.3B
Income tax: -$121.0M
Net income: -$2.2B
EPS (basic): $-2.46
EPS (diluted): $-2.46

Balance sheet

Total assets: $2.1B
Current assets: $688.6M
Total liabilities: $584.8M
Current liabilities: $280.3M
Shareholders’ equity: $1.5B

Cash flow

Operating cash flow: -$94.6M
Investing cash flow: -$46.7M
Financing cash flow: $133.5M
Net cash flow: -$6.7M

Statements via Polygon.io (SEC filings)

NASDAQ: TLRY

$5.03 +1.82%

15-minute delayed · data by Polygon.io

Past year

$3.60 $21.00

52-week range

Market cap: $590.8M
EPS (diluted): $-2.46
Shares outstanding: 117.5M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Jan 23, 2015

Market data by Polygon.io · prices are 15-minute delayed

Auto-generated

At a glance

Reported a net loss of $2.2B in FY2025.
Revenue grew 60% from FY2021 to FY2025.
Gross margin of 29.3%, net margin -265.6%.
Trading 76% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.